Study arms | Health centre | Number of households | Populationb | Baselinec | Follow-upc | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Presence of LLIN among/in | HMM | Vitamin A | Praziquantel | Presence of LLIN among/in | HMM | Vitamin A | Praziquantel | ||||||||||
Adults | Children | EPWa | Households | Children | Pregnant women | Households | Children | Pregnant women | |||||||||
Intervention | Nankumba | 1,019 | 4,310 | 1,144 | 273 | 934 (91.7%) | 1,003 (87.7%) | 107 (39.2%) | 17 (1.5%) | 989 (86.5%) | 17 (0.4%) | 1,004 (98.5%) | 1,141 (99.7%) | 100 (36.6%) | 40 (3.5%) | 1,007 (88%) | 173 (4%) |
Katuli | 1,209 | 4,846 | 406 | 263 | 1,048 (86.7%) | 358 (88.2%) | 141 (53.6%) | 17 (4.2%) | 349 (86%) | 7 (0.1%) | 1,173 (97.7%) | 293 (92.5%) | 216 (82.1%) | 2 (0.5%) | 324 (79.8%) | 63 (1.3%) | |
Sub-total | 2,228 | 9,156 | 1,550 | 536 | 1,982 (89%) | 1,361 (87.8%) | 248 (46.3%) | 34 (2.2%) | 1,338 (86.3%) | 24 (0.3%) | 2,177 (97.7%) | 1,434 (92.5%) | 316 (59%) | 42 (2.7%) | 1,331 (85.9%) | 236 (2.6%) | |
Control | Phirilongwe | 885 | 2,795 | 762 | 178 | 673 (76%) | 548 (71.9%) | 79 (44.4%) | 175 (23%) | 713 (93.6%) | 0 | 883 (99.8%) | 665 (87.3%) | 103 (57.9%) | 180 (23.6%) | 726 (95.3%) | 11 (0.4%) |
Mase | 1,398 | 5,215 | 960 | 309 | 1,229 (87.9%) | 829 (86.4%) | 289 (93.5%) | 34 (3.5%) | 911 (94.9%) | 103 (2%) | 1,199 (85.8%) | 960 (100%) | 228 (73.8%) | 13 (1.4%) | 880 (91.7%) | 304 (5.8%) | |
Sub-total | 2,283 | 8,010 | 1,722 | 487 | 1,902 (83.3%) | 1,377 (80%) | 368 (75.6%) | 209 (12.1%) | 1,624 (94.3%) | 103 (1.3%) | 2,082 (91.2%) | 1,625 (94.4%) | 331 (68%) | 193 (11.2%) | 1,606 (93.3%) | 315 (3.9%) |